-
1 . Academic Journal
Gefapixant, a P2X3 receptor antagonist, for the treatment of refractory or unexplained chronic cough: a randomised, double-blind, controlled, parallel-group, phase 2b trial
- 저자
- by Smith, Jaclyn; McGarvey, Lorcan; Birring, Surinder; Hull, James; Carr, Warner W, et al.
- 소스
- In The Lancet Respiratory Medicine August 2020 8(8):775-785